Market Indices
Sector Heatmap
ANIP — ANI Pharmaceuticals, Inc.
NasdaqANI Pharmaceuticals, Inc.
- O
- 73.16
- H
- 73.27
- L
- 71.73
- V
- 300.03K
ANIP — Latest News & Headlines
13 StoriesANI Pharmaceuticals (NASDAQ:ANIP) Stock: Insider Stephen Carey Sells 2,850 Shares - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Stock: Insider Stephen Carey Sells 2,850 Shares MarketBeat
Data on an eye implant for chronic eye inflammation will be presented in a late-breaking talk Oct. 9. - Stock Titan
Data on an eye implant for chronic eye inflammation will be presented in a late-breaking talk Oct. 9. Stock Titan
Understanding Momentum Shifts in (ANIP) - Stock Traders Daily
Understanding Momentum Shifts in (ANIP) Stock Traders Daily
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts Yahoo! Finance Canada
1 Small-Cap Stock for Long-Term Investors and 2 We Ignore - StockStory
1 Small-Cap Stock for Long-Term Investors and 2 We Ignore StockStory
ANI Pharmaceuticals: Cortrophin’s Q4 Test, With Generics Funding The Build (NASDAQ:ANIP) - Seeking Alpha
ANI Pharmaceuticals: Cortrophin’s Q4 Test, With Generics Funding The Build (NASDAQ:ANIP) Seeking Alpha
ANI Pharmaceuticals Receives FDA Approval for Generic Everolimus Tablets for Oral Suspension - Quiver Quantitative
ANI Pharmaceuticals Receives FDA Approval for Generic Everolimus Tablets for Oral Suspension Quiver Quantitative
Should FDA Generic Everolimus Approval Require Action From ANI Pharmaceuticals (ANIP) Investors? - Simply Wall Street
Should FDA Generic Everolimus Approval Require Action From ANI Pharmaceuticals (ANIP) Investors? Simply Wall Street
Implied Volatility Surging for ANI Pharmaceuticals Stock Options - TradingView
Implied Volatility Surging for ANI Pharmaceuticals Stock Options TradingView
After selling 2,850 shares, ANI Pharmaceuticals (ANIP) CFO holds 168,993 shares. - Stock Titan
After selling 2,850 shares, ANI Pharmaceuticals (ANIP) CFO holds 168,993 shares. Stock Titan
183,066 Shares of ANI Pharmaceuticals, Inc. $ANIP Acquired by Bank of America Corp DE - MarketBeat
183,066 Shares of ANI Pharmaceuticals, Inc. $ANIP Acquired by Bank of America Corp DE MarketBeat
ANI Pharmaceuticals (ANIP) FDA Approval Puts Fair Value Back In Focus - Simply Wall Street
ANI Pharmaceuticals (ANIP) FDA Approval Puts Fair Value Back In Focus Simply Wall Street
3 Profitable Stocks Worth Investigating - The Globe and Mail
3 Profitable Stocks Worth Investigating The Globe and Mail